Page last updated: 2024-10-29

iohexol and Epithelial Ovarian Cancer

iohexol has been researched along with Epithelial Ovarian Cancer in 1 studies

Iohexol: An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.
iohexol : A benzenedicarboxamide compound having N-(2,3-dihydroxypropyl)carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and an N-(2,3-dihydroxypropyl)acetamido group at the 5-position.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Mingzhu, L1
Yaqiong, G1
Mengru, L1
Wei, W1

Other Studies

1 other study available for iohexol and Epithelial Ovarian Cancer

ArticleYear
Prediction of BRCA gene mutation status in epithelial ovarian cancer by radiomics models based on 2D and 3D CT images.
    BMC medical imaging, 2021, 11-26, Volume: 21, Issue:1

    Topics: Adult; Aged; Carcinoma, Ovarian Epithelial; Contrast Media; Female; Genes, BRCA1; Genes, BRCA2; Huma

2021